Curative Biotechnology (CUBT) News Today $0.0080 0.00 (0.00%) (As of 11/20/2024 ET) Add Compare Share Share Headlines Stock AnalysisChartFinancialsSEC FilingsShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Zacks Dividend Fund Institutional Class Shares (ZDIIX) Stock Price, Quote, News & Analysis - Seeking AlphaJuly 21, 2024 | seekingalpha.comCurative Biotechnology, Inc. Announces Nomination of Dr. Theresa Heah to Board of DirectorsMarch 31, 2024 | globenewswire.comSFRX Seafarer Exploration Corp.March 29, 2024 | seekingalpha.comCurative Biotechnology, Inc. Announces Nomination of Dr. Theresa Heah to Board of DirectorsMarch 22, 2024 | globenewswire.comShould You Expect Strong Financial Growth For Legend Biotech Corporation (LEGN)?January 22, 2024 | insidermonkey.comCurative Biotechnology, Inc.?: Curative Biotechnology, Inc. Announces Nomination of Dr. Jeffrey Liebmann to Board of DirectorsOctober 31, 2023 | finanznachrichten.de3 Best Biotech Stocks to Add to Your PortfolioAugust 18, 2023 | thestreet.comCurative Biotechnology Announces Establishment of Japanese Subsidiary for Licensing Transactions and Asset AcquisitionsJune 6, 2023 | finance.yahoo.comSacramento Biotech NewsJune 2, 2023 | bizjournals.comCurative Biotechnology, Inc. Files Patent on Ophthalmic FormulationMay 24, 2023 | finance.yahoo.comCurative Biotechnology, Inc.?: Curative Biotechnology Announces Completion of IND Enabling Reformulated Metformin HCL Eye Drop StudyJanuary 5, 2023 | finanznachrichten.deCurative Biotechnology, Inc. (CUBT)November 12, 2022 | finance.yahoo.comCurative Biotechnology refiles for NYSE uplisting, $8M offeringNovember 8, 2022 | seekingalpha.comCurative Biotechnology, Inc.: Curative Biotechnology Announces Intent to Uplist to NYSE American ExchangeOctober 20, 2022 | finanznachrichten.deCurative Biotechnology files for NYSE American uplisting, $8M IPOSeptember 30, 2022 | seekingalpha.comCurative Biotechnology Stock (OTC:CUBT), Short Interest ReportSeptember 26, 2022 | benzinga.comCUBT Curative Biotechnology, Inc.September 22, 2022 | seekingalpha.comCurative Biotechnology Inc. Adds Biotech Veteran Lawrence S. Zaslow to Board of DirectorsJune 16, 2022 | finance.yahoo.comCurative Biotechnology, Inc. Names Cary Sucoff to Board of DirectorsMay 12, 2022 | finance.yahoo.comCurative Biotechnology, Inc. Appoints Cary Sucoff to Board of DirectorsMay 12, 2022 | finance.yahoo.comCan You Pay a Mortgage With a Credit Card?May 4, 2022 | yahoo.comCurative Biotechnology Announces Good Laboratory Practice (GLP) Toxicology Studies with Metformin Eye Drop Formulations for Treatment of Macular DegenerationMay 3, 2022 | finance.yahoo.comCurative Biotechnology Announces Toxicology Studies Under Good Laboratory Practices (GLP) for Metformin Eye Drop Formulations for Treatment of Macular DegenerationMay 3, 2022 | finance.yahoo.comCurative signs agreement with NEI to develop age-related eye disease treatmentMarch 21, 2022 | seekingalpha.comEmily Y. Chew, M.D. of the National Eye Institute Assigned Principal InvestigatorMarch 21, 2022 | morningstar.comCurative Biotechnology Announces Cooperative Research and Development Agreement(CRADA) with the National Eye Institute (NEI) for Clinical Evaluation of its Proprietary Ocular Metformin Formulation in Age-Related Macular DegenerationMarch 21, 2022 | finance.yahoo.com[UPDATED] CURATIVE BIOTECHNOLOGY ANNOUNCES OCULAR TOLERANCE EVALUATION OF METFORMIN EYE DROP FORMULATIONS FOR TREATMENT OF MACULAR DEGENERATIONNovember 24, 2021 | finance.yahoo.comCURATIVE BIOTECHNOLOGY ANNOUNCES OCULAR TOLERANCE EVALUATION OF METFORMIN EYE DROP FORMULATIONS FOR TREATMENT OF MACULAR DEGENERATIONNovember 24, 2021 | finance.yahoo.comCURATIVE BIOTECHNOLOGY ANNOUNCES DR. CATHERINE SOHN AS SPECIAL ADVISOR TO BOARD AND CEOOctober 12, 2021 | finance.yahoo.comCURATIVE BIOTECHNOLOGY ANNOUNCES IMT504 LICENSE FOR DEVELOPMENT OF PROPRIETARY NEXT-GEN ...October 8, 2021 | apnews.comCurative Biotechnology Announces IMT504 License For Development Of Proprietary Next-Gen COVID-19 VaccineOctober 7, 2021 | prnewswire.comCURATIVE BIOTECHNOLOGY ANNOUNCES IMT504 LICENSE FOR DEVELOPMENT OF PROPRIETARY NEXT-GEN COVID-19 VACCINEOctober 7, 2021 | finance.yahoo.comCurative Biotechnology, Inc. Announces Addition of Dr. Nicholas Boulis to Scientific and ...September 3, 2021 | apnews.com Get Curative Biotechnology News Delivered to You Automatically Sign up to receive the latest news and ratings for CUBT and its competitors with MarketBeat's FREE daily newsletter. Email Address New Year, New Opportunity! 2 AI Stocks Under $10 Ready to Soar (Ad)As we step into 2025, artificial intelligence (AI) stocks continue to dominate headlines, and now is the perfect moment to position yourself for the coming year’s potential. Our latest research has uncovered two must-buy AI stocks currently trading under $10/share – an affordable entry with promising growth potential. These stocks are flying under the radar, but it’s only a matter of time before they gain mainstream attention. 👉 Click here to access your FREE report now! CUBT Media Mentions By Week CUBT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CUBT News Sentiment▼0.000.46▲Average Medical News Sentiment CUBT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CUBT Articles This Week▼00▲CUBT Articles Average Week Get Curative Biotechnology News Delivered to You Automatically Sign up to receive the latest news and ratings for CUBT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Marpai News Today BioRestorative Therapies News Today Ontrak News Today Mangoceuticals News Today NewGenIvf Group News Today Global Cord Blood News Today Hybrid Energy News Today Pacific Health Care Organization News Today DaVita News Today Fresenius Medical Care News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:CUBT) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Curative Biotechnology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Curative Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
